Delivery Order SPE2DR25D2014-SPE2DR26FZ86E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,577.52 to AmerisourceBergen Drug Corp for the supply of Phenylephrine 2.5% Eye Drop in 15ml quantities. This firm fixed price delivery order, issued on November 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and is scheduled for completion by November 26, 2025, with...
- The Defense Logistics Agency awarded a $1,163.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phenylephrine 2.5% eye drops (15 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-competitive, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenylephrine 2.5% eye drops (15 mL) with a ceiling value of $1,536.13. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is scheduled for completion by July 30, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $9,340.20 to AmerisourceBergen Drug Corp for the supply of Phenylephrine 2.5% Eye Drop in 15mL quantities. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Phenylephrine 2.5% eye drops in 2 mL bottles. The $1,680.36 contract has an ultimate completion date of March 29, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA, which serves as the primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,805.20, is for the delivery of Phenylephrine 2.5% eye drops in 15 ml quantities. The contract is a delivery order with a firm fixed price and an ultimate completion date of May 2, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN4M1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenylephrine 2.5% eye drops, 15 mL, with a ceiling value of $1,637.80 and a period of performance through April 16, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit prime contractor, for the supply of Phenylephrine 2.5% eye drops in 15 ml bottles. The $2,032.64 contract has a completion date of March 5, 2024 and was awarded on March 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is a subsidiary of Amerisourcebergen Corporation, a leading global...
- The Defense Logistics Agency awarded a $4,642.13 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Phenylephrine 2.5% eye drops in 2 mL units. This contract employs firm fixed-price pricing with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for July 28, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,435.54 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 15 ml bottles of Phenylephrine 2.5% eye drops. This Delivery Order was placed under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ86EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Phenylephrine 2.5% Eye Drop in a 15ML format, with a ceiling value of $1,101.72. This competitively awarded, non-set-aside contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed price terms. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical program (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contracting history demonstrates its capability to fulfill diverse pharmaceutical procurement requirements at varying order values through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/2/25 |